Jemperli OverviewDostarlimab, sold under the brand name Jemperli, is a monoclonal antibody medication used for the treatment of endometrial cancer. The most common adverse reactions (≥20%) were fatigue/asthenia, nausea, diarrhea, anemia, and constipation. The most common grade 3 or 4 adverse reactions (≥2%) were anemia and transaminases increased. ...
Read more Jemperli Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dostarlimab
Recent Jemperli Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 500mg/10ml
NDC Database Records for Jemperli: (1 result)Sorted by National Drug Code
- 0173-0898 Jemperli 50 mg/ml Intravenous Injection by Glaxosmithkline LLC